List of works - Gowthami M Arepally

Atomic description of the immune complex involved in heparin-induced thrombocytopenia

scientific article

Bad weed: synthetic cannabinoid-associated coagulopathy

scientific article published on 17 January 2019

Determinants of PF4/heparin immunogenicity

scientific article

Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.

scientific article

Dynamic antibody-binding properties in the pathogenesis of HIT.

scientific article

Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia

scientific article published on 18 June 2018

Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia

scientific article

Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly

scientific article

Novel diagnostic assays for heparin-induced thrombocytopenia

scientific article

PF4/heparin complexes are T cell-dependent antigens

scientific article

Pathogenesis of heparin-induced thrombocytopenia and thrombosis

scientific article

Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia

scientific article published on 22 November 2016

Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway

scientific article published on 11 October 2018

Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia

scientific article published on 01 November 2018

Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications

scientific article

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia

scientific article

List of works by Gowthami M Arepally

Atomic description of the immune complex involved in heparin-induced thrombocytopenia

Bad weed: synthetic cannabinoid-associated coagulopathy

Determinants of PF4/heparin immunogenicity

Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.

Dynamic antibody-binding properties in the pathogenesis of HIT.

Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia

Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly

Novel diagnostic assays for heparin-induced thrombocytopenia

PF4/heparin complexes are T cell-dependent antigens

Pathogenesis of heparin-induced thrombocytopenia and thrombosis

Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia

Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway

Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia

Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia